Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Mueck, Wolfgang, Stampfuss, Jan, Kubitza, Dagmar, Becka, Michael
Published in Clinical pharmacokinetics (01.01.2014)
Published in Clinical pharmacokinetics (01.01.2014)
Get full text
Journal Article
Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects
Boettcher, Michael, Thomas, Dirk, Mueck, Wolfgang, Loewen, Stephanie, Arens, Erich, Yoshikawa, Kenichi, Becker, Corina
Published in European journal of clinical pharmacology (01.04.2021)
Published in European journal of clinical pharmacology (01.04.2021)
Get full text
Journal Article
Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects
Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang
Published in Journal of clinical pharmacology (01.02.2007)
Published in Journal of clinical pharmacology (01.02.2007)
Get more information
Journal Article
Rivaroxaban: A New Oral Factor Xa Inhibitor
Perzborn, Elisabeth, Roehrig, Susanne, Straub, Alexander, Kubitza, Dagmar, Mueck, Wolfgang, Laux, Volker
Published in Arteriosclerosis, thrombosis, and vascular biology (01.03.2010)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.03.2010)
Get full text
Journal Article
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Halabi, Atef, Maatouk, Haidar, Klause, Norbert, Lufft, Volkmar, Wand, Dominic D., Philipp, Thomas, Bruck, Heike
Published in British journal of clinical pharmacology (01.11.2010)
Published in British journal of clinical pharmacology (01.11.2010)
Get full text
Journal Article
Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects
Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang
Published in Journal of clinical pharmacology (01.05.2006)
Published in Journal of clinical pharmacology (01.05.2006)
Get more information
Journal Article
Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation
Tanigawa, Takahiko, Kaneko, Masato, Hashizume, Kensei, Kajikawa, Mariko, Ueda, Hitoshi, Tajiri, Masahiro, Paolini, John F., Mueck, Wolfgang
Published in Drug metabolism and pharmacokinetics (2013)
Published in Drug metabolism and pharmacokinetics (2013)
Get full text
Journal Article
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
Mueck, Wolfgang, Borris, Lars C, Dahl, Ola E, Haas, Sylvia, Huisman, Menno V, Kakkar, Ajay K, Kälebo, Peter, Muelhofer, Eva, Misselwitz, Frank, Eriksson, Bengt I
Published in Thrombosis and haemostasis (2008)
Published in Thrombosis and haemostasis (2008)
Get more information
Journal Article
Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients
Kaneko, Masato, Tanigawa, Takahiko, Hashizume, Kensei, Kajikawa, Mariko, Tajiri, Masahiro, Mueck, Wolfgang
Published in DRUG METABOLISM AND PHARMACOKINETICS (2013)
Published in DRUG METABOLISM AND PHARMACOKINETICS (2013)
Get full text
Journal Article
Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics
Becker, Corina, Boettcher, Michael, Muenster, Uwe, Loewen, Stephanie, Lobmeyer, Maximilian, Mueck, Wolfgang
Published in AAPS open (01.11.2022)
Published in AAPS open (01.11.2022)
Get full text
Journal Article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism
Reinecke, Isabel, Solms, Alexander, Willmann, Stefan, Spiro, Theodore E., Peters, Gary, Weitz, Jeffrey I., Mueck, Wolfgang, Garmann, Dirk, Schmidt, Stephan, Zhang, Liping, Fox, Keith A. A., Berkowitz, Scott D.
Published in Journal of thrombosis and thrombolysis (01.07.2020)
Published in Journal of thrombosis and thrombolysis (01.07.2020)
Get full text
Journal Article
Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation
Burghaus, Rolf, Coboeken, Katrin, Gaub, Thomas, Kuepfer, Lars, Sensse, Anke, Siegmund, Hans-Ulrich, Weiss, Wolfgang, Mueck, Wolfgang, Lippert, Joerg
Published in PloS one (22.04.2011)
Published in PloS one (22.04.2011)
Get full text
Journal Article
Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
DeJesus, Edwin, Saleh, Soundos, Cheng, Sue, van der Mey, Dorina, Becker, Corina, Frey, Reiner, Unger, Sigrun, Mueck, Wolfgang
Published in Pulmonary circulation (01.04.2019)
Published in Pulmonary circulation (01.04.2019)
Get full text
Journal Article
Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects
Zhao, Xia, Sun, Peihong, Zhou, Ying, Liu, Yuwang, Zhang, Huilin, Mueck, Wolfgang, Kubitza, Dagmar, Bauer, Richard J., Zhang, Hong, Cui, Yimin
Published in British journal of clinical pharmacology (01.07.2009)
Published in British journal of clinical pharmacology (01.07.2009)
Get full text
Journal Article
Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling
Solms, Alexander, Frede, Matthias, Berkowitz, Scott D., Hermanowski‐Vosatka, Anne, Kubitza, Dagmar, Mueck, Wolfgang, Spiro, Theodore E., Willmann, Stefan, Yan, Xiaoyu, Zhang, Liping, Garmann, Dirk
Published in CPT: pharmacometrics and systems pharmacology (01.11.2019)
Published in CPT: pharmacometrics and systems pharmacology (01.11.2019)
Get full text
Journal Article